The holiday season is in full swing, and all eyes are on the retail industry. John Gagliardi, Regional Brokerage Consultant at Fidelity, stopped by to give us a retail roundup.
Gagliardi points out that internet retail has led the way, but specialty retail has shown signs of life. He analyzed the performance of the XRT ETF, which has a variety of online and brick-and-mortar retailers including Amazon and Macy's. With a price to earnings ratio of just 11 for Macy's, Gagliardi says this could represent a value opportunity for investors.
It's important to remember that most sectors and industry groups participate in a bull market, he says. Gagliardi shows us the performance of the IBUY ETF, focused on online retailers only, and highlights that it performed much better than XRT.
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
